Enova CEO sells 7,852 shares after option exercise
Enova International CEO Steven E. Cunningham reported an exercise-and-sell stock transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Enova International CEO Steven E. Cunningham reported an exercise-and-sell stock transaction. He exercised non-qualified stock options for 3,696 shares of common stock at an exercise price of $31.98 per share on April 28, 2026. On the same date, he sold a total of 7,852 shares of common stock in open-market transactions at a price of $175.50 per share. After these trades, he directly owns 122,945 shares of Enova common stock and holds 7,391 non-qualified stock options with an exercise price of $31.98 per share that are scheduled to expire on August 3, 2028.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
Cunningham Steven E
Role
Chief Executive Officer
Sold
7,852 shs ($1.38M)
Approx. gross sale proceeds
$1.38M
Approx. exercise cost
$118K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR | 3,696 | $0.00 | $0.00 |
| Sale | Common stock, par value $0.00001 per share | 4,156 | $175.50 | $729K |
| Exercise | Common stock, par value $0.00001 per share | 3,696 | $31.98 | $118K |
| Sale | Common stock, par value $0.00001 per share | 3,696 | $175.50 | $649K |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) with limited SAR — 7,391 contracts (Direct);
Common stock, par value $0.00001 per share — 122,945 shares (Direct)
Footnotes (3)
- F1. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- F2. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- F3. The options vested in substantially equal one-third increments on each of the following dates: February 2, 2023, February 3, 2024 and February 3, 2025.
Key Figures
Shares sold: 7,852 shares
Sale price: $175.50 per share
Options exercised: 3,696 shares
+4 more
7 metrics
Shares sold
7,852 shares
Open-market sales on April 28, 2026 at $175.50 per share
Sale price
$175.50 per share
Price for 7,852 common shares sold on April 28, 2026
Options exercised
3,696 shares
Non-qualified stock option exercise at $31.98 per share
Option exercise price
$31.98 per share
Strike price of exercised non-qualified options
Shares owned after
122,945 shares
Direct Enova common stock holdings following transactions
Options remaining
7,391 options
Non-qualified stock options outstanding after exercise, expiring August 3, 2028
Option expiration
August 3, 2028
Expiration date of remaining non-qualified stock options
Key Terms
Non-Qualified Stock Option, limited stock appreciation right, Change in Control, Offer Value Per Share, +1 more
5 terms
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy) with limited SAR"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
limited stock appreciation right financial
"The limited stock appreciation right ("SAR") and employee stock option were granted in tandem."
Change in Control financial
"The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
tender offer financial
""Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Enova (ENVA) CEO Steven Cunningham report?
Enova CEO Steven Cunningham reported exercising stock options and selling common shares. He exercised 3,696 options at $31.98 per share and sold 7,852 common shares at $175.50 per share, all dated April 28, 2026.
What stock options did the Enova (ENVA) CEO exercise in this Form 4?
Cunningham exercised 3,696 non-qualified stock options with an exercise price of $31.98 per share, linked to a tandem limited stock appreciation right. The options relate to Enova common stock and are part of an award that vested in thirds during 2023, 2024, and 2025.
What are Steven Cunningham’s Enova (ENVA) holdings after these transactions?
After the reported transactions, Cunningham directly holds 122,945 shares of Enova common stock. He also retains 7,391 non-qualified stock options with an exercise price of $31.98 per share, scheduled to expire on August 3, 2028, according to the Form 4 data.
What is the nature of the Enova (ENVA) CEO’s remaining stock options?
The remaining 7,391 options are non-qualified stock options with a limited stock appreciation right attached. They carry an exercise price of $31.98 per share and an expiration date of August 3, 2028, following vesting in roughly equal tranches from 2023 through 2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates